Suspension - Amryt Pharma plc
TEMPORARY SUSPENSION OF TRADING ON AIM
AMRYT PHARMA PLC
At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended from 21/05/2019 7:30am, pending publication of an admission document.
ORDINARY SHARES OF 1P EACH, FULLY PAID (BDD1LS5) (GB00BDD1LS57)
If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0) 20 7408 4090.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Quick facts: Amryt Pharma PLC
Market Cap: £64.99 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE